| Affiliation: | 1. EORTC Headquarters, Brussels, Belgium;2. Netherlands Cancer Institute—Antoni van Leeuwenhoek, Amsterdam, Netherlands;3. University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy;4. Melanoma Institute Australia, The University of Sydney, and Mater and Royal North Shore Hospitals, Sydney, NSW, Australia;5. Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane, QLD, Australia;6. Hospices Civils de Lyon Cancer Institute, Lyon, France;7. Alfred Hospital, Melbourne, VIC, Australia;8. N N Blokhin Cancer Research Center, Moscow, Russia;9. Fiona Stanley Hospital & Edith Cowan University, Perth, WA, Australia;10. Westmead and Blacktown Hospitals, Melanoma Institute Australia and the University of Sydney, NSW, Australia;11. Peter Maccallum Cancer Centre, Melbourne, VIC, Australia;12. Hospital Clinic de Barcelona & Universitat de Barcelona & CIBERER, ISCIII, Barcelona, Spain;13. Istituto Nazionale Tumori IRCCS, Fondazione G Pascale, Naples, Italy;14. Royal Marsden Hospital, London, UK;15. Christie NHS Foundation Trust, Manchester, UK;p. Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland;q. University Hospital Essen, Essen and German Cancer Consortium, Heidelberg, Germany;r. Radboud University Medical Center Nijmegen, Nijmegen, Netherlands;s. Washington University School of Medicine, St Louis, MO, USA;t. Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy;u. Amsterdam University Medical Center, VUMC, Amsterdam, Netherlands;v. Aix-Marseille University, Hôpital de la Timone, Marseille, France;w. Skin Cancer Center, Hannover Medical School, Hannover, Germany;x. Centre Hospitalier de l''Université de Montréal (CHUM), Centre de Recherche du CHUM, Montreal, QC, Canada;y. Merck & Co, Kenilworth, NJ, USA;z. Gustave Roussy Cancer Institute & University Paris-Saclay, Villejuif, France;11. Princess Máxima Center, Utrecht, Netherlands;12. University Medical Center Utrecht, Utrecht, Netherlands |
